IMPLANET Announces Its 2022 Financial Calendar
24 Janvier 2022 - 6:00PM
Business Wire
Regulatory News:
IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168,
eligible for PEA-PME equity savings plans), a medical technology
company specialized in vertebral implants, today announces its
schedule for the publication of financial information for
2022Etats-Unis de son expansion commerciale aux Etats-Unis,.
Event
Dates*
2021 Full-Year Results
March 15, 2022
2022 First-Quarter Revenue
April 19, 2022
Annual General Meeting
April 26, 2022
2022 First-Half Revenue
July 11, 2022
2022 First-Half Results
September 20, 2022
2022 Third-Quarter Revenue
October 18, 2022
(*): These dates can be subject to modifications. Press releases
will be published after market close.
Upcoming financial event: – 2021 Full-Year
Results, on March 15, 2022 after market close.
About IMPLANET
Founded in 2007, IMPLANET is a medical technology company that
manufactures high-quality implants for orthopedic surgery. Its
activity revolves around a comprehensive innovative solution for
improving the treatment of spinal pathologies (JAZZ®) complemented
by the product range offered by Orthopaedic & Spine Development
(OSD), acquired in May 2021 (thoraco-lumbar screws, cages and
cervical plates). Implanet’s tried-and-tested orthopedic platform
is based on the traceability of its products. Protected by four
families of international patents, JAZZ® has obtained 510(k)
regulatory clearance from the Food and Drug Administration (FDA) in
the United States, the CE mark in Europe and ANVISA approval in
Brazil. IMPLANET employs 29 staff and recorded a consolidated
revenue of €6.1 million in 2021. Based near Bordeaux in France,
IMPLANET opened a US subsidiary in Boston in 2013. IMPLANET is
listed on the Euronext Growth market in Paris. For further
information, please visit www.implanet.com.
The Company would like to remind readers that the table for
monitoring the equity line (OCA, BSA) and the number of shares
outstanding is available on its website:
http://www.implanet-invest.com/suivi-des-actions-80
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220124005550/en/
IMPLANET Ludovic Lastennet, CEO David Dieumegard, CFO
Tel.: +33 (0)5 57 99 55 55 investors@Implanet.com
NewCap Investor Relations Mathilde Bohin Nicolas Fossiez
Tel.: +33 (0)1 44 71 94 94 implanet@newcap.eu
NewCap Media Relations Nicolas Merigeau Tel.: +33 (0)1 44
71 94 94 implanet@newcap.eu
Implanet (EU:ALIMP)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Implanet (EU:ALIMP)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024